tiprankstipranks
Advertisement
Advertisement

RCUS Stock Latest News

Arcus Biosciences Stockholders Back Directors and Governance Measures
Company AnnouncementsArcus Biosciences Stockholders Back Directors and Governance Measures
1d ago
8K
RCUS
Arcus Biosciences Advances Casdatifan With New Phase 1 Bioequivalence Study
PremiumCompany Announcements
Arcus Biosciences Advances Casdatifan With New Phase 1 Bioequivalence Study
2d ago
RCUS
Arcus Biosciences initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Arcus Biosciences initiated with an Outperform at LifeSci Capital
9d ago
RCUS
Analyst Initiates Buy on Arcus Biosciences, Citing Best-in-Class HIF-2α Inhibitor Casdatifan and Expanded ccRCC Opportunity After Merck Setbacks
PremiumRatings
Analyst Initiates Buy on Arcus Biosciences, Citing Best-in-Class HIF-2α Inhibitor Casdatifan and Expanded ccRCC Opportunity After Merck Setbacks
9d ago
RCUS
Arcus enters clinical trial collaboration, supply agreement with Bristol Myers
PremiumThe Fly
Arcus enters clinical trial collaboration, supply agreement with Bristol Myers
10d ago
BMY
RCUS
Arcus Biosciences assumed with a Buy at Truist
PremiumThe FlyArcus Biosciences assumed with a Buy at Truist
26d ago
RCUS
Arcus Biosciences price target raised to $22 from $20 at Morgan Stanley
Premium
The Fly
Arcus Biosciences price target raised to $22 from $20 at Morgan Stanley
1M ago
RCUS
Arcus Biosciences Bets Big on Cascadifan
Premium
Company Announcements
Arcus Biosciences Bets Big on Cascadifan
1M ago
RCUS
Arcus Advances Quemliclustat With Completed Phase 1 Metabolism Study
PremiumCompany Announcements
Arcus Advances Quemliclustat With Completed Phase 1 Metabolism Study
1M ago
RCUS
Arcus Biosciences rises 12.2%
PremiumThe Fly
Arcus Biosciences rises 12.2%
2M ago
RCUS
Merck setback has positives and negatives for Arcus Biosciences, says BofA
PremiumThe Fly
Merck setback has positives and negatives for Arcus Biosciences, says BofA
2M ago
MRK
RCUS
Merck study miss not a read for Arcus, says H.C. Wainwright
PremiumThe Fly
Merck study miss not a read for Arcus, says H.C. Wainwright
2M ago
MRK
RCUS
Arcus Biosciences: Buy Rated on Pipeline Control, PD‑1 Backbone Validation, and Upside from Emerging I&I and RCC Programs
PremiumRatingsArcus Biosciences: Buy Rated on Pipeline Control, PD‑1 Backbone Validation, and Upside from Emerging I&I and RCC Programs
2M ago
RCUS
Balanced Risk Profile After TIGIT Failure and Gilead Exit Supports Neutral Stance on Arcus
Premium
Ratings
Balanced Risk Profile After TIGIT Failure and Gilead Exit Supports Neutral Stance on Arcus
2M ago
RCUS
Arcus Biosciences discontinues Star-121 study with Gilead due to futility
Premium
The Fly
Arcus Biosciences discontinues Star-121 study with Gilead due to futility
2M ago
GILD
RCUS
Arcus Biosciences price target lowered to $47 from $49 at Leerink
PremiumThe Fly
Arcus Biosciences price target lowered to $47 from $49 at Leerink
2M ago
GILD
RCUS
Arcus Ends Key Lung Cancer Trials in Gilead Partnership Reset
PremiumCompany Announcements
Arcus Ends Key Lung Cancer Trials in Gilead Partnership Reset
2M ago
8K
RCUS
Wedbush raises Arcus Biosciences price target to $41, adds to Best Ideas List
PremiumThe Fly
Wedbush raises Arcus Biosciences price target to $41, adds to Best Ideas List
2M ago
RCUS
Arcus Biosciences Announces COO Resignation and Transition Plan
PremiumCompany Announcements
Arcus Biosciences Announces COO Resignation and Transition Plan
3M ago
8K
RCUS
Damora Therapeutics appoints Jennifer Jarrett as CEO
PremiumThe FlyDamora Therapeutics appoints Jennifer Jarrett as CEO
3M ago
DMRA
RCUS
Arcus Biosciences price target raised to $45 from $44 at Citi
Premium
The Fly
Arcus Biosciences price target raised to $45 from $44 at Citi
3M ago
RCUS
Arcus Biosciences: Casdatifan’s Differentiated HIF-2α Profile Versus Belzutifan Supports High-Risk Buy Rating
Premium
Ratings
Arcus Biosciences: Casdatifan’s Differentiated HIF-2α Profile Versus Belzutifan Supports High-Risk Buy Rating
3M ago
RCUS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >